Cargando…
Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) represent a rare and heterogenous tumor entity. Importantly, the highly proliferative subgroup of neuroendocrine carcinoma (GEP-NEC) is characterized by high resistance to conventional chemotherapy. Consequently, there is an urgent need to id...
Autores principales: | Dizdar, Levent, Oesterwind, Kira A., Riemer, Jasmin C., Werner, Thomas A., Mersch, Sabrina, Möhlendick, Birte, Schütte, Sina C., Verde, Pablo E., Raba, Katharina, Topp, Stefan A., Stoecklein, Nikolas H., Esposito, Irene, Knoefel, Wolfram T., Krieg, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352407/ https://www.ncbi.nlm.nih.gov/pubmed/28039474 http://dx.doi.org/10.18632/oncotarget.14207 |
Ejemplares similares
-
Survivin and XIAP – two potential biological targets in follicular thyroid carcinoma
por: Werner, Thomas A., et al.
Publicado: (2017) -
New Model for Gastroenteropancreatic Large-Cell Neuroendocrine Carcinoma: Establishment of Two Clinically Relevant Cell Lines
por: Krieg, Andreas, et al.
Publicado: (2014) -
Survivin and XIAP: two valuable biomarkers in medullary thyroid carcinoma
por: Werner, Thomas A, et al.
Publicado: (2016) -
Prognostic and Clinicopathological Significance of Survivin in Colorectal Cancer: A Meta-Analysis
por: Krieg, Andreas, et al.
Publicado: (2013) -
A Robust Method to Analyze Copy Number Alterations of Less than 100 kb in Single Cells Using Oligonucleotide Array CGH
por: Möhlendick, Birte, et al.
Publicado: (2013)